loader
Please Wait
Applying Filters...

Annual Sales of Olaparib reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

Menu
$ API Ref.Price (USD/KG) : 7,761Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Alliance revenue - Lynparza

02 14Lynparza

PharmaCompass

01

Brand Name : Lynparza

Olaparib

arrow
BioJapan 2024
Not Confirmed

02

Brand Name : Lynparza

Olaparib

arrow
BioJapan 2024
Not Confirmed

03

Brand Name : Lynparza

Olaparib

arrow
BioJapan 2024
Not Confirmed

Brand Name : Lynparza

arrow
BioJapan 2024
Not Confirmed

Olaparib

Main Therapeutic Indication : Oncology

Currency : USD

2020 Revenue in Millions : 725

2019 Revenue in Millions : 444

Growth (%) : 63

blank

04

Brand Name : Lynparza

Olaparib

arrow
BioJapan 2024
Not Confirmed

Brand Name : Lynparza

arrow
BioJapan 2024
Not Confirmed

Olaparib

Main Therapeutic Indication : Oncology

Currency : USD

2021 Revenue in Millions : 989

2020 Revenue in Millions : 725

Growth (%) : 36

blank

05

Brand Name : Lynparza

Olaparib

arrow
BioJapan 2024
Not Confirmed

06

Brand Name : Lynparza